Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAddition: Revision: v3.4.2. Deletions: removal of a government funding lapse notice and related operating-status updates (Revision: v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and NIH Clinical Center operating status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedChanges consist of minor UI/text updates, including showing the glossary, capitalization tweaks, and a version note, which do not alter the study content or key information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section updated to include Massachusetts as a study location and the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check92 days agoChange DetectedPubMed publications note updated to 'automatically filled in from PubMed' with an added revision tag (v3.3.2); the prior text describing PubMed publications (v3.2.0) was replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.